KCT0005879招募中未知
Exploratory clinical trial of low-dose radiotherapy in patients treated with immune checkpoint inhibitor and stereotactic body radiotherapy for metastatic cancer
Seoul Metropolitan Government Seoul National University Boramae Medical Center0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1. aged 19 years or older
- •2. histologically confirmed as malignant neoplasm
- •3. 3 or more measurable lesions according to RECIST1.1
- •4. needs treatment with immune checkpoint inhibitor per medical oncologist
- •5. suitable for stereotactic body radiotherapy per radiation oncologist
- •6. 1 or more extracranial lesion suitable for stereotactic body radiotherapy
- •7. adequate CBC/differential count as follows: absolute neutrophil count = 1,000/mm3; hemoglobin = 9 g/dL, platelet = 75,000/mm3)
- •8. in patients with brain metastases, the patient has to be neurologically stable with no progressive intracranial lesion after local treatment (surgery or radiotherapy)
- •9. has provided study-specific informed consent prior to study registration
排除标准
- •1. Eastern Cooperative Oncology Group performance 3 or 4
- •2. enrolled in another clinical trial evaluating drug or medical device
- •3. malignant cord compression or impending cord compression by metastatic lesion requiring urgent surgery or radiotherapy
- •4. impossible to comply to stereotactic body radiotherapy due to pain, neurology, or other underlying medical conditions
- •5. pregnant or has pregnancy plans
- •6. has synchronous malignancy requiring treatment other than the current metastatic cancer responsible for study enrollment (completely resected non-melanoma skin cancer with curative intent or carcinoma in situ are not included)
- •7. has received systemic steroid or other immunosuppressive therapy within 2 weeks prior to study enrollment
- •8. has undergone systemic treatment for active autoimmune disease within the prior 2 years, has current evidence of clinically severe autoimmune disease, or has other medical syndrome requiring systemic steroid or immunosuppression (patients requiring intermittent use of bronchodilator or steroid inhalation, and patients requiring local steroid injection are not included. Patients with stable hypothyroidism or type I diabetes treated with hormone replacement therapy, and patients who have recovered from pediatric type asthma/atopic dermatitis are also eligible for the study)
- •9. has active infection requiring systemic treatment
研究者
相似试验
招募中
不适用
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerbreast cancerJPRN-UMIN000029478QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology30
招募中
1 期
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerD001943Breast cancerJPRN-jRCTs032180154Karasawa Kumiko30
进行中（未招募）
1 期
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerD001943Breast cancerJPRN-jRCTs032180153Karasawa Kumiko20
招募中
1 期
A phase I/II clinical trial of radical radiotherapy using proton for early breast cancerBreast cancerJPRN-UMIN000016206Fukui Prefectural Hospital20
招募中
1 期
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerBreast cancerJPRN-UMIN000010848ational Institute of Radiological Sciences20